Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2019
Reporting Period: This filing reports on events occurring on March 11, 2019, specifically regarding upcoming investor presentations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The primary event is the announcement of upcoming presentations by executive officers to investors and analysts.
Guidance, Outlook, and Management Commentary
- Investor Presentations: Executive officers intend to use the material filed as Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated March 2019) for upcoming meetings with investors and analysts.
- Regulation FD Disclosure: The information provided, including the referenced exhibit, is furnished pursuant to Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
- Emerging Growth Company Status: The registrant is identified as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Important Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation dated March 2019) for specific financial data, guidance, and strategic outlook, as the 8-K text only references this document.
- Verify the company's status as an emerging growth company and its election regarding accounting standard transition periods.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act unless specifically incorporated by reference in other filings.